Dilution of candidates: The case of iron-related genes in restless legs syndrome

European Journal of Human Genetics

Volumn 21, Issue 4, 2013, Pages 410-414

  Oexle, Konrad ^a   Schormair, Barbara ^b   Ried, Janina S ^b   Czamara, Darina ^c   Heim, Katharina ^b   Frauscher, Birgit ^d   Högl, Birgit ^d   Trenkwalder, Claudia ^e,f   Martin Fiedler, G ^g   Thiery, Joachim ^g   Lichtner, Peter ^b   Prokisch, Holger ^b   Specht, Michael ^c   Müller Myhsok, Bertram ^c   Döring, Angela ^b   Gieger, Christian ^b   Peters, Annette ^b   Wichmann, H Erich ^b,h   Meitinger, Thomas ^a,b   Winkelmann, Juliane ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e PARACELSUS ELENA KLINIK   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

iron parameters; linear regression; logistic regression; MEIS1 haplotype; power calculation; restless legs syndrome

Indexed keywords

FERRITIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; CORL2 GENE; GENE; GENE LOCUS; HFE GENE; HUMAN; INTRON; IRON BLOOD LEVEL; IRON METABOLISM; KATNAL2 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOSINE TRIPHOSPHATASES; CASE-CONTROL STUDIES; FERRITINS; GENETIC ASSOCIATION STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEODOMAIN PROTEINS; HUMANS; IRON; MEMBRANE PROTEINS; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TRANSFERRIN; RESTLESS LEGS SYNDROME; TRANSFERRIN;

EID: 84875051815     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.193     Document Type: Article

References (33)

1. Trenkwalder C, Paulus W: Restless legs syndrome: pathophysiology, clinical presentationand management. Nat Rev Neurol 2010; 6: 337-346.
2. Berger K, von Eckardstein A, Trenkwalder C et al: Iron metabolism and the risk ofrestless legs syndrome in an elderly general population-the MEMO-Study. J Neurol2002; 249: 1195-1199. (Pubitemid 35025093)
3. Högl B, Kiechl S, Willeit J et al: Restless legs syndrome: a community-based study ofprevalence, severity, and risk factors. Neurology 2005; 64: 1920-1924. (Pubitemid 40800707)
4. Pantaleo NP, Hening WA, Allen RP, Earley CJ: Pregnancy accounts for most ofthe gender difference in prevalence of familial RLS. Sleep Med 2010; 11: 310-313.
5. Winkelmann J, Schormair B, Lichtner P et al: Genome-wide association study ofrestless legs syndrome identifies common variants in three genomic regions. Nat Genet2007; 39: 1000-1006. (Pubitemid 47185185)
6. Stefansson H, Rye DB, Hicks A et al: A genetic risk factor for periodic limb movementsin sleep. N Engl J Med 2007; 357: 639-647. (Pubitemid 47267233)
7. Schormair B, Kemlink D, Roeske D et al: PTPRD (protein tyrosine phosphatasereceptor type delta) is associated with restless legs syndrome. Nat Genet 2008; 40:946-948.
8. Vilarino-Guell C, Farrer MJ, Lin SC: A genetic risk factor for periodic limb movementsin sleep. N Engl J Med 2008; 358: 425-427. (Pubitemid 351159253)
9. Kemlink D, Polo O, Frauscher B et al: Replication of estless legs syndrome loci in threeEuropean populations. J Med Genet 2009; 46: 315-318.
10. Winkelmann J, Czamara D, Schormair B et al: Genome-wide association studyidentifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.PLoS Genet 2011; 7: e1002171.
11. O'Keeffe ST, Gavin K, Lavan JN: Iron status and restless legs syndrome in the elderly.Age Ageing 1994; 23: 200-203. (Pubitemid 24158288)
12. Allen RP, Earley CJ: The role of iron in restless legs syndrome. Mov Disord 2007; 22:S440-S448.
13. Allen RP, Picchietti D, Hening WA et al: Restless legs syndrome: diagnostic criteria,special considerations, and epidemiology. A report from the restless legs syndromediagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med2003; 4: 101-119. (Pubitemid 36527231)
14. Wichmann HE, Gieger C, Illig T: KORA-gen-resource for population genetics, controlsand a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67(Suppl 1):S26-S30.
15. Oexle K, Ried JS, Hicks AA et al: Novel association to the proprotein convertasePCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels.Hum Mol Genet 2011; 20: 1042-1047.
16. Purcell S, Neale B, Todd-Brown K et al: PLINK: a tool set for whole-genomeassociation and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575. (Pubitemid 47330214)
17. Constantine CC, Gurrin LC, McLaren CE et al: SNP selection for genes of iron metabolismin a study of genetic modifiers of hemochromatosis. BMC Med Genet 2008; 9: 18.
18. Hentze MW, Muckenthaler MU, Galy B, Camaschella C: Two to tango: regulation ofMammalian iron metabolism. Cell 2010; 142: 24-38.
19. Marchini J, Howie B, Myers S et al: A new multipoint method for genome-wideassociation studies by imputation of genotypes. Nat Genet 2007; 39: 906-913. (Pubitemid 47014502)
20. Whitfield JB, Cullen LM, Jazwinska EC et al: Effects of HFE C282Y and H63Dpolymorphisms and polygenic background on iron stores in a large community sampleof twins. Am J Hum Genet 2000; 66: 1246-1258. (Pubitemid 30468782)
21. Catoire H, Dion PA, Xiong L et al: Restless legs syndrome-associated MEIS1 riskvariant influences iron homeostasis. Ann Neurol 2011; 70: 170-175.
22. Sun ER, Chen CA, Ho G et al: Iron and restless legs syndrome. Sleep 1998; 21: 381-387.
23. Frauscher B, Gschliesser V, Brandauer E et al: The severity range of restless legssyndrome (RLS) and augmentation in a prospective patient cohort: association withferritin levels. Sleep Med 2009; 10: 611-615.
24. Trenkwalder C, Högl B, Benes H, Kohnen R: Augmentation in restless legs syndrome isassociated with low ferritin. Sleep Med 2008; 9: 572-574. (Pubitemid 351837476)
25. Curgunlu A, Döventaş A, Karadeniz D et al: Prevalence and characteristics of restlesslegs syndrome (RLS) in the elderly and the relation of serum ferritin levels with diseaseseverity: Hospital-based study from Istanbul, Turkey. Arch Gerontol Geriatr 2012; 55:73-76.
26. Quinn C, Uzbeck M, Saleem I et al: Iron status and chronic kidney disease predictrestless legs syndrome in an older hospital population. Sleep Med 2011; 12: 295-301.
27. Kim KW, Yoon IY, Chung S et al: Prevalence, comorbidities and risk factors of restlesslegs syndrome in the Korean elderly population-results from the Korean LongitudinalStudy on Health and Aging. J Sleep Res 2010; 19: 87-92.
28. Oexle K: A remark on rare variants. J Hum Genet 2010; 55: 219-226.
29. Pe'er I, Yelensky R, Altshuler D, Daly MJ: Estimation of the multiple testing burden forgenomewide association studies of nearly all common variants. Genet Epidemiol2008; 32: 381-385. (Pubitemid 351656309)
30. Sokal RR, Rohlf FJ: Biometry. New York: WH Freeman and Company, 1995, p 578.
31. Hsieh FY, Bloch DA, Larsen MD: A simple method of sample size calculation for linearand logistic regression. Stat Med 1998; 17: 1623-1634. (Pubitemid 28367842)
32. Bull SB: Sample size and power determination for a binary outcome and an ordinalexposure when logistic regression analysis is planned. Am J Epidemiol 1993; 137:676-684. (Pubitemid 23118093)
33. Demidenko E: Sample size determination for logistic regression revisited. Stat Med2007; 26: 3385-3397. (Pubitemid 47161998)